Anabolix
MuscleMecca Sponsors
Staff member
Sponsor
- Joined
- Dec 25, 2024
- Messages
- 658
- Points
- 28
What Is YK-11, and What Should You Know About Its Effects and Risks?
Introduction
YK-11 is a synthetic compound that is frequently marketed online as a SARM (selective androgen receptor modulator) and as a “myostatin inhibitor.” It has gained attention in bodybuilding and fitness communities because of claims involving muscle growth, strength, and body composition.However, YK-11 is important to distinguish from well-studied pharmaceutical compounds. Human clinical evidence is extremely limited, and it has not been approved by the FDA as a drug or dietary supplement for muscle building, athletic performance, or any other general-use purpose. In a December 2025 warning letter, the FDA specifically identified YK-11 products marketed as SARMs as unapproved new drugs. (U.S. Food and Drug Administration)
What Is YK-11?
YK-11 is a synthetic compound associated with androgen-receptor activity and research into myostatin-related pathways. Myostatin is a biological regulator that normally acts as a negative regulator of skeletal-muscle growth. Research into myostatin inhibition has therefore attracted interest in conditions involving muscle wasting as well as muscle-development research. (PubMed)YK-11 is frequently described online as a SARM with additional myostatin-inhibiting properties. However, many of the claims made about it come from laboratory or animal research rather than controlled human clinical trials.
That distinction is essential when evaluating information about this compound.
Why Is YK-11 Popular in Bodybuilding?
YK-11 has become popular largely because of claims that it may support:- Lean muscle development
- Strength and training performance
- Changes in body composition
- Muscle-cell growth
- Myostatin-related pathways
Therefore, marketing claims should not be confused with established clinical benefits.
What Does the Research Actually Show?
One published study investigated YK-11 in an experimental model of sepsis-related muscle wasting. Researchers reported that YK-11 affected myostatin-related pathways and produced potentially interesting effects in mice. (PubMed)This type of research can help scientists understand biological mechanisms, but it does not establish that the same effects, benefits, or safety profile occur in healthy humans.
This is one of the biggest limitations surrounding YK-11: there is considerably more online discussion than high-quality human clinical evidence.
Understanding Myostatin
Myostatin, also known as GDF-8, is a member of the transforming growth factor-beta family and plays an important role in regulating skeletal-muscle development and growth. Scientific reviews describe myostatin as a negative regulator of muscle mass. (PubMed)Because of this biological role, researchers have explored different approaches to modifying myostatin signaling.
However, the fact that myostatin inhibition is scientifically interesting does not automatically mean that a particular compound marketed as a “myostatin inhibitor” will produce predictable muscle-building effects in humans.
Is YK-11 an Approved Medicine?
No. YK-11 does not have FDA approval for bodybuilding, muscle growth, athletic performance, or general therapeutic use.The FDA has repeatedly warned that SARMs and similar bodybuilding products are not approved dietary supplements and have not undergone FDA review for safety and effectiveness. (U.S. Food and Drug Administration)
This is particularly relevant when products are sold online with labels such as “research use only.” A research-use label does not establish that a product is appropriate or safe for human consumption.
Potential Safety Concerns
The lack of adequate human research makes it difficult to establish the complete safety profile of YK-11.More broadly, the FDA warns that products marketed as SARMs have been associated with serious adverse effects, including liver injury, acute liver failure, cardiovascular problems, sexual dysfunction, infertility, and other potentially serious complications. (U.S. Food and Drug Administration)
The FDA has also specifically reported testing a YK-11-containing product in connection with an adverse event involving a consumer who subsequently suffered a stroke. This does not establish that YK-11 itself caused that individual event, but it demonstrates why products containing YK-11 should not automatically be considered low-risk. (U.S. Food and Drug Administration)
Hormonal Considerations
Compounds marketed as SARMs interact with androgen-related biological pathways. Consequently, it is inappropriate to assume that they are completely free from endocrine effects simply because they are not conventional anabolic steroids.The long-term hormonal consequences of YK-11 in humans remain insufficiently characterized. There is also limited evidence to establish how different doses, durations, combinations, or individual health conditions might affect hormonal function.
Product Quality Matters
The package shown with this discussion is labeled YK-11, 10 mg/tablet, 100 tablets. These are product-label specifications and should not be interpreted as a medically established dosage or recommendation.For products sold outside regulated pharmaceutical systems, the stated ingredient and strength cannot automatically be assumed to correspond to the actual contents. FDA has warned that bodybuilding products marketed as SARMs may be of unknown quality and potentially harmful. (U.S. Food and Drug Administration)
Independent laboratory analysis can help determine what is present in a particular sample, but testing does not make an unapproved compound FDA-approved or establish that it is safe for human use.
YK-11 vs. Marketing Claims
A useful way to evaluate YK-11 information is to separate three categories:Laboratory research:
Provides information about biological mechanisms and possible areas for future research.
Human clinical evidence:
Provides stronger evidence about effectiveness, appropriate medical use, and safety.
Online bodybuilding claims:
May describe individual experiences, but these reports cannot establish predictable results or long-term safety.
For YK-11, the first category has some research, while reliable human clinical evidence remains very limited.
Important Safety Perspective
YK-11 should not be treated as an ordinary dietary supplement simply because it may be sold in tablet or capsule form. The FDA considers marketed YK-11/SARM products to be unapproved drugs, and the agency has warned about serious risks associated with SARMs and similar bodybuilding products. (U.S. Food and Drug Administration)Anyone experiencing symptoms such as yellowing of the skin or eyes, dark urine, severe abdominal pain, unusual fatigue, chest pain, shortness of breath, or other significant health changes should seek medical attention rather than relying on online bodybuilding advice. (U.S. Food and Drug Administration)
Conclusion
YK-11 is a research compound frequently marketed online as a SARM and myostatin-related muscle-building compound. Its popularity comes largely from proposed mechanisms involving androgen receptors and myostatin pathways, but its human clinical evidence is limited.Research involving experimental models provides interesting information about its biological activity, but it should not be interpreted as proof of predictable muscle-building benefits or long-term safety in humans. (PubMed)
Order Now
DragonPharmaStore Crypto Special Offers
Stock up while inventory lasts. Some offers are available for a limited time and may end without notice.
-----------------------------------------------------------
Sweet Surprise
At DragonPharmaStore.to, every order gets a little extra.
No matter the size of your order, you'll receive 4 FREE Cialis 20mg tablets in blister packs at absolutely no additional cost.








